Coty Revenue Tops in Fiscal Q4 Down 8%

Coty (NYSE:COTY) reported mixed Q4 FY2025 results, with revenue of $1.25 billion exceeding analyst expectations despite an 8% year-over-year decline, attributed partly to strategic inventory normalization. However, profitability significantly underperformed, with non-GAAP EPS of $(0.05) missing consensus and free cash flow sharply falling to $34.9 million, reflecting broad weakness across Prestige and Consumer Beauty divisions and ongoing cost pressures. Management projects sequential sales improvement in FY2026, anticipating a return to like-for-like growth in the second half as new product launches and cost-saving initiatives take effect, while targeting over $350 million in H1 FY2026 free cash flow.

Analysis

Coty's Q4 FY2025 results present a challenging operational picture despite a revenue beat. The company reported revenue of $1,252.4 million, an 8% year-over-year decline that nonetheless surpassed analyst estimates, largely attributed to a management-led inventory reduction at retailers. However, profitability metrics revealed significant weakness, with a non-GAAP EPS of $(0.05) missing the consensus forecast of $0.01 and key indicators showing severe deterioration. Non-GAAP operating income fell 37%, adjusted EBITDA declined 23%, and free cash flow plummeted 70.1% to just $34.9 million. These pressures were broad-based, with the Prestige division's revenue falling 5% and the Consumer Beauty division's revenue dropping 12%, accompanied by a sharp compression in the latter's adjusted EBITDA margin to 4.8% from 9.2% a year prior. While management is executing on cost-saving programs and shifting production to mitigate tariffs, the near-term outlook remains cautious. The company guided for continued like-for-like sales declines in the first half of FY2026 before anticipating a return to growth in the second half, contingent on new product launches and the completion of inventory normalization. The forecast for H1 FY2026 free cash flow to exceed $350 million stands in stark contrast to the current quarter's performance and will be a critical measure of the turnaround's credibility.

Key Decisions for Investors

• Given the significant miss on profitability and the sharp decline in free cash flow, investors should treat Coty as a 'show-me' story, as the investment thesis now hinges entirely on a back-half weighted recovery in FY2026.
• Monitor the execution of new fragrance launches and any signs of margin stabilization in the Consumer Beauty segment, as these are the primary catalysts management has cited for a return to growth.
• The aggressive H1 FY2026 free cash flow guidance of over $350 million is a key metric to track; failure to meet this target after the dramatic Q4 drop would severely undermine management's credibility and the viability of the turnaround plan.
• Consider the current valuation in the context of guided sales declines for the next two quarters, weighing whether the market has adequately priced in the significant near-term operational and execution risks.